Evidence map›Paper›PMID 34964704›Full record

ArticleAutophagy2022

AP2M1 mediates autophagy-induced CLDN2 (claudin 2) degradation through endocytosis and interaction with LC3 and reduces intestinal epithelial tight junction permeability.

Ashwinkumar Subramenium Ganapathy, Kushal Saha, Eric Suchanec, Vikash Singh, Aayush Verma, Gregory Yochum, Walter Koltun, Meghali Nighot, Thomas Ma, Prashant Nighot

Open access · greenAbstract read
In one paragraph

Article in Autophagy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Extracellular Vesicles Derived fromNanomaterials (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ashwinkumar Subramenium GanapathyDivision of Gastroenterology and Hepatology, Department of Medicine, Pennsylvania State College of Medicine, Hershey, PA, USA.ORCID 0000-0001-5254-9431
Kushal SahaDivision of Gastroenterology and Hepatology, Department of Medicine, Pennsylvania State College of Medicine, Hershey, PA, USA.
Eric SuchanecDivision of Gastroenterology and Hepatology, Department of Medicine, Pennsylvania State College of Medicine, Hershey, PA, USA.
Vikash SinghDivision of Hematology and Oncology, Department of Pediatrics, Pennsylvania State College of Medicine, Hershey, Pa, USA.
Aayush VermaDivision of Gastroenterology and Hepatology, Department of Medicine, Pennsylvania State College of Medicine, Hershey, PA, USA.
Gregory YochumDivision of Colon and Rectal Surgery, Department of Surgery, Pennsylvania State College of Medicine, Hershey, PA, USA.
Walter KoltunDivision of Colon and Rectal Surgery, Department of Surgery, Pennsylvania State College of Medicine, Hershey, PA, USA.
Meghali NighotDivision of Gastroenterology and Hepatology, Department of Medicine, Pennsylvania State College of Medicine, Hershey, PA, USA.
Thomas MaDivision of Gastroenterology and Hepatology, Department of Medicine, Pennsylvania State College of Medicine, Hershey, PA, USA.
Prashant NighotDivision of Gastroenterology and Hepatology, Department of Medicine, Pennsylvania State College of Medicine, Hershey, PA, USA.ORCID 0000-0003-2368-7290
Penn State Milton S. Hershey Medical Center · US

Funding

Unfolded Protein Response and Autophagy in T Helper Cell Effector FunctionP20GM121176 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI VOJO P DERETIC · 2017 to 2026
$24.9M
Intestinal Barrier, Probiotic Bacteria, and the Gut-Liver AxisR01DK121073 · NIDDK · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MA, THOMAS Y · 2019 to 2023
$2.4M
Bifidobacterium bifidum modulation of intestinal barrier and intestinal inflammation.R01DK106072 · NIDDK · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI MA, THOMAS Y · 2016 to 2019
$1.8M
Regulation of Intestinal Tight Junction Barrier and Inflammation by AutophagyR01DK114024 · NIDDK · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI NIGHOT, PRASHANT · 2017 to 2021
$1.8M
Role of the chloride channel ClC-2 in intestinal tight junction barrier recoveryK01DK100562 · NIDDK · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI NIGHOT, PRASHANT · 2014 to 2018
$684k
NIDDK NIH HHS K01 DK100562NIDDK NIH HHS R01 DK106072NIDDK NIH HHS R01 DK114024NIGMS NIH HHS P20 GM121176
6 · The paper itself

Abstract

The intestinal epithelial tight junctions (TJs) provide barrier against paracellular permeation of lumenal antigens. Defects in TJ barrier such as increased levels of pore-forming TJ protein CLDN2 (claudin-2) is associated with inflammatory bowel disease. We have previously reported that starvation-induced macroautophagy/autophagy enhances the TJ barrier by degrading pore-forming CLDN2. In this study, we examined the molecular mechanism underlying autophagy-induced CLDN2 degradation. CLDN2 degradation was persistent in multiple modes of autophagy induction. Immunolocalization, membrane fractionation, and pharmacological inhibition studies showed increased clathrin-mediated CLDN2 endocytosis upon starvation. Inhibition of clathrin-mediated endocytosis negated autophagy-induced CLDN2 degradation and enhancement of the TJ barrier. The co-immunoprecipitation studies showed increased association of CLDN2 with clathrin and adaptor protein AP2 (AP2A1 and AP2M1 subunits) as well as LC3 and lysosomes upon starvation, signifying the role of clathrin-mediated endocytosis in autophagy-induced CLDN2 degradation. The expression and phosphorylation of AP2M1 was increased upon starvation. In-vitro, in-vivo (mouse colon), and ex-vivo (human colon) inhibition of AP2M1 activation prevented CLDN2 degradation.

Indexed as

Claudin-2Inflammatory Bowel DiseasesAdaptor Protein Complex 2Adaptor Proteins, Signal TransducingAnimalsAutophagyClathrinClaudinsEndocytosisHumansMicePermeabilitySirolimusTight JunctionsAdaptor Protein Complex 2Adaptor Proteins, Signal TransducingClathrinClaudin-2ClaudinsCLDN2 protein, humanSirolimusAutophagyCLDN2inflammatory bowel diseaseintestinal permeabilitytight junction

Identifiers

PMID34964704
PMCPMC9466623
OpenAlexW4200094286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.